During the development and regeneration of skeletal muscle, many growth factors, such as basic fibroblast growth factor (bFGF, FGF-2) and myostatin, have been shown to play regulating roles. bFGF contributes to promote proliferation and to inhibit differentiation of skeletal muscle, whereas myostatin plays a series of contrasting roles. In order to elucidate whether the expression of bFGF has any relationship with the expression of myostatin in skeletal muscle cells, we constructed a eukaryotic expression vector for the expression of exogenous bFGF in murine C2C12 myoblasts. Quantitative RT-PCR assays indicated that with the increase of the expression of exogenous bFGF gene, the expression of endogenous myostatin gene was suppressed at mRNA level and protein level.
Skeletal muscle development and regeneration during embryonic and adult life consisting of proliferation, migration and differentiation of myogenic cells are regulated by several growth factors, such as fibroblast growth factors (FGF), insulin-like growth factor-I (IGF-I) and its alternative splicing variant [1, 2] . Among these regulators basic fibroblast growth factor (bFGF, FGF-2) has been confirmed to be an important factor for stimulating skeletal muscle regeneration [3−5] . Whereas myostatin, a member of the transforming growth factor-β (TGF-β) superfamily, exerts a negative regulation role during the course of development and regeneration of skeletal muscle [6, 7] . bFGF is a multifunctional growth factor and one of its key functions is to stimulate the proliferation of cells derived from mesodermal and neuroectodermal tissues [8− 11] . bFGF has been found in many organs, solid tissues, tumors and cultured cells including muscle cells [12−17] and is regarded as a potent factor in the enhancement of muscle regeneration in vivo [4, 5] . Impaired expression of the endogenous bFGF gene in rat skeletal muscle caused by ischemia and reperfusion may be one of the reasons for delayed wound healing in an injury model [18, 19] . Furthermore, a positive correlation between bFGF and the speed of muscle regeneration has been reported [3] . Injury causes an influx of monocytes and macrophages, which can degrade the extra-cellular matrix and release the stored bFGF. Therefore, the endogenous expression and secretion of bFGF could be reduced [20−23] . Clinically, bFGF has been used in the treatment of muscle wounds [24] .
Myostatin is expressed in both myogenic precursor cells during early stages of embryogenesis and skeletal muscles in adults, and is considered as a negative regulator of skeletal muscle growth [6] . It has been postulated that myostatin is produced and secreted by muscle fibers, and then act extracellularly themselves. When loading induced muscle fiber hypertrophy, stimulating the proliferation of satellite cells has been thought to play a crucial role [25, 26] . Furthermore, the expression of myostatin was induced in regenerating areas where activated satellite cells were proliferating [7] . These facts implicate that myostatin might play an important role in balancing the actions of growth factors during regeneration of skeletal muscle. In cell culture, myostatin inhibits the proliferation of C2C12 myo-blasts through the control of myogenin expression. Moreover, myostatin could control cell cycles and prevent cells from apoptosis [27−29] .
Because of the opposite roles of bFGF and myostatin in skeletal muscle development and regeneration, it would be interesting to know whether any relationship exists between bFGF and myostatin genes in expression. To reveal the possible effects of bFGF on the expression of myostatin, exogenous bFGF genes was expressed in murine C2C12 myoblasts and the expression levels of endogenous myostatin genes were measured.
Materials and Methods

Construction of expression vector
Total RNA of Chinese LUXI Yellow Cattle was isolated from spleen tissue with Trizol reagent (Invitrogen, Shanghai, China) according to the manufacturer's protocol. Reverse transcription (RT) reaction was performed as follows: 1 μg of total RNA was reverse transcribed by Moloney murine leukemia virus (MMLV) reverse transcriptase (Progema, Madison, USA) using oligo(dT) as a primer at 42 ºC for 1 h and the RT product was directly used in polymerase chain reactions (PCR). For amplification of the bovine bFGF encoding sequence by nested PCR, two sets of primers were synthesized based on published cDNA sequences (GenBank accession No. NM174056). The first set of primers were: sense strand primer 5'-CTCCAGGGGCTCGGGGAC-3', identical to the region of nucleotide 63−80; antisense primer 5'-TCGGCA-ACAGCACACCCA-3', complementary to nucleotide 1365− 1382. The PCR reaction was performed in a total 25 μl of reaction system containing RT products, DNA polymerase (Promega, Shanghai, China), dNTP and buffer. PCR conditions were as follows: initial denaturation at 95 ºC for 5 min, followed by 30 cycles of 50 s at 95 ºC, 50 s at 64 ºC, 3 min at 72 ºC, and a final 10 min extension at 72 ºC. The second set of primers were: the sense primer 5'-CT-AAGCTTATGGCCGCCGGGA-3' corresponding to nucleotide 104−116 with a HindIII site at 5' end (underlined); the antisense primer 5'-CTGGATCCTCAGCTCTTAGCA-GAC-3' complementary to nucleotide 556−571 containing a BamHI site (underlined). The PCR reaction conditions were the same as those in the first set except that the extension time was 1 min. Nested PCR product was subcloned into vector pMD18-T (TaKaRa, Dalian, China) and the bFGF sequence was verified by DNA sequencing. For the construction of expression vector, the primer 5'-ATGAATTCCACCATGGCCGCCGGGAGC-3' containing a Kozak sequence (in bold) and an EcoRI site (underlined), and the primer 5'-TAGCGGCCGCTCAGCTCTTAGCAG-3' containing a NotI site (underlined) were used to amplify the bFGF coding sequence from pMD18-T-bFGF. The reaction conditions were similar to those in the amplification of the bFGF coding sequence except that the annealing temperature was 62 ºC. The amplification products were subcloned into vector pCMV-neo, an expression vector originating from pEGFP-N1, and the final vector pCMVneo-bFGF was constructed. pCMV-neo-bFGF was transformed into Escherichia coli DH5α.
Cell culture and transfection
Murine C2C12 myoblasts (purchased from ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM) and Ham F-12 (DMEM/F12=1:1; Invitrogen) supplemented with 10% fetal bovine serum (FBS; Sigma, Shanghai, China) at 37 ºC with 5% CO 2 in a humidified atmosphere. Transfection was performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol with modification. Briefly, 1×10
5 cells in 1 ml of DMEM/F12 containing 10% FBS were seeded in 60-mm dishes and grew to 70%−75% confluence. pCMV-neo-bFGF DNA (8 μg) and Lipofectamine 2000 were added separately in tubes each containing 500 μl of DMEM/F12, mixed well and allowed to stand for 5 min at room temperature. Then, the two mixtures were combined together and incubated for 20 min at room temperature. One milliliter of medium containing Lipofectamine packaged plasmid DNA was added into each 60-mm dish and mixed gently by rocking the plate back and forth. The medium was replaced after 6 h of transfection and cells were incubated at 37 ºC with 5% CO 2 in a humidified atmosphere for total 24 h. Afterward cells were divided into two groups. In one group, cells were passaged at 1:10 into fresh DMEM/F12 supplemented with 10% heat-inactivated FBS. Selection was exerted by adding G418 at a concentration of 500 ng per milliliter of medium and the culture was performed for 3 weeks in constant conditions following incubation in DMEM/F12 with 0.5% FBS for 48 h. In the other group, cells were maintained for 24 h in DMEM/F12 medium containing 0.5% heat-inactivated FBS. Then cells in the two groups were harvested separately by washing three times with DPBS (Invitrogen) without calcium chloride and magnesium chloride and incubating in fresh DMEM/F12 containing 0.5% heat-inactivated FBS for 1 h. The cells were used to extract total RNA for determination of levels of gene transcription, while the culture media were collected http://www.abbs.info; www.blackwellpublishing.com/abbs to detect secreted bFGF by ELISA. For the control, empty vector pCMV-neo was transfected and cells were harvested after transfection for 24 h in DMEM/F12 with 0.5% FBS. To further confirm the effects of bFGF on expression of myostatin, non-transfected C2C12 cells grown to 80% confluence were cultured in DMEM/F12 with 0.5% FBS for 48 h and then transferred into supernatants collected from three group dishes, respectively. mRNA levels of bFGF, myostatin and glyceraldehydes 3-phosphate dehydrogenase (GAPDH) genes were detected by real-time RT-PCR.
Quantitative RT-PCR
The relative mRNA abundances of bFGF, myostatin and GAPDH genes were assessed by a real-time RT-PCR. Total RNA was extracted from the two groups of cells and control cells using Trizol reagent (Invitrogen) according to the manufacturer's protocol. The first stranded complementary DNA was synthesized using Superscript preamplification kit (Promega) according to the manufacturer's protocol. A total of 20 μl of the quantitative RT-PCR reaction mixture contained 1×SYBR GREEN PCR master mix (Applied Biosystems, Foster City, USA) were mixed with 0.5 pM each of primers and 3 μg cDNA. The reaction was carried out in a 96-well microtiter plate on an ABI PRISM 7900 Sequence Detector System (Applied Biosystems). The reaction mixture was first incubated at 50 ºC for 2 min and 95 ºC for 10 min, and followed by a 35-cycle amplification reaction. The steps of amplification reactions were denatured at 95 ºC for 15 s, followed by annealing for 40 s and extension at 72 ºC for 30 s. Annealing temperature, primer sequence and products size of bFGF, myostatin and GAPDH genes are shown in Table  1 . Myostatin and bFGF levels were both normalized with GAPDH level, and relative abundances of myostatin or bFGF mRNA in control cells, transient expression cells and transgenic cells were plotted.
Detection of bFGF secreted into cell culture medium
Contents of bFGF protein in cell culture media were detected with indirect ELISA. A 96-well flat-bottomed assay plate was coated with monoclonal antibody against bFGF (Santa Cruz, Santa Cruz, USA) at the concentration of 5 μg/ml in 0.2 M sodium carbonate buffer and kept at 4 ºC overnight. Plate was then washed three times with phosphate buffered solution containing 1% Tween-20 (PBST) and blocked with 1% skim milk powder for 2 h at 37 ºC in a humidified atmosphere, followed by washing. Cell culture supernatants were added to the wells and incubated for 1 h at 37 ºC in a humidified atmosphere, followed by washing. Polyclonal antibody against bFGF was added to the wells and incubated for 1 h at 37 ºC. The plate was washed again and a secondary antibody labeled with horseradish peroxidase (HRP; Santa Cruz) was added into wells and incubated for 1 h at 37 ºC. After washing, wells were added with TMB (Promega) and kept for 10 min in dark conditions at room temperature for color development. The reaction was stopped with 2 M H 2 SO 4 and the optical density values were recorded in an ELISA reader at wavelength 450 nm.
Data and statistical analysis
Results are expressed as mean±SEM. Statistical analysis was performed using SPSS software and Student's ttest was used to determine significant differences in means between groups. P<0.05 was considered the significant difference statistically.
Results
In this study, we investigated the effects of expression of exogenous bFGF on the expression of endogenous myostatin in mouse C2C12 myoblasts. To avoid fluctuation of activity of bFGF molecules and to reflect the effects more directly on the expression of myostatin gene by bFGF, the method of direct adding recombinant bFGF to cultured cells was abandoned, and instead a eukaryotic expression vector pCMV-neo-bFGF was constructed and Fig. 1(A)] and by high translation level of protein in transfected cells supernatant [ Fig. 1(B) ]. Although the expression levels of bFGF genes in transgenic cell samples were significantly higher than in control cells (P<0.01), it was significantly lower than in transient expressional cells (P<0.01). These facts reflect that under present experimental conditions the bFGF gene was efficiently expressed, driven by the strong cytomegalovirus (CMV) promoter upon entering the cells, whereas the integrated exogenous bFGF gene could only express to a certain extent, subject to the influence of the environment of the insertion sites, i.e., the so called "position effect" of the fate of the integrated foreign genes in genome. Fig. 2(A) shows that on the expression of exogenous bFGF gene, the contents of myostatin mRNA in transient expression cells and in transgenic cells decreased significantly in comparison to those in control cells (P<0.01). In contrary to the expression of exogenous bFGF gene, the content of endogenous myostatin mRNA in transgenic cells was significantly higher than those in transient expression cells (P<0.05). This was anticipated if bFGF molecules could exert down regulation on the expression of endogenous myostatin genes in myoblasts and related cell types. In other words, the mRNA of endogenous myostatin genes decreased following the increase of exogenous bFGF gene expression [ Fig. 2(B) ]. From the above data we could conclude tentatively that exogenous bFGF suppressed the . mRNA levels of bFGF in SC and TC were significantly higher than that in CC (*P<0.01), but the levels in SC were lower than that in TC significantly (*P<0.01). The data were the relative abundance of each mRNA taking the transcription of GAPDH as internal control. (B) bFGF protein levels in cell supernatants from three samples of cells were measured after standardized with regard to cell numbers. Results were in good agreement with mRNA levels. http://www.abbs.info; www.blackwellpublishing.com/abbs expression of myostatin gene in myoblasts related cell types.
To test whether there is a tendency that bFGF impairs the expression of the myostatin gene on a dose-dependent manner in C2C12 myoblasts, the media of transgenic cells, transient expression cells and control cells were collected separately and added into dishes of C2C12 cells. The data showed that mRNA contents of the myostatin gene were decreasing along with increasing bFGF protein levels in media (P<0.01) (Fig. 3) . At the same time the expression of transfected endogenous bFGF gene was suppressed by exogenous bFGF contained in the cell culture medium (P<0.01) (Fig. 3) . However, in this experiment the actual weight of bFGF was not measured and the cell numbers in the culture dish were not standardized. We could not conclude that the endogenous myostatin gene was suppressed by the exogenous bFGF in a strict dose-dependent manner and further experiments are needed.
Discussion
The mechanism of regulation on skeletal muscle growth and regeneration is a complicated one, in which several factors might be involved. Among these factors, bFGF mainly promotes proliferation and inhibition of the terminal differentiation of myogenic cells, while myostatin is considered as a negative regulator of the skeletal muscle growth and regeneration. Thus, there may be a connection between the behavior of bFGF and of myostatin. To study whether bFGF suppresses the expression of the myostatin gene during the course of skeletal muscle development and regeneration, we constructed a eukaryotic expression vector of bFGF and expressed in transient status and in transgenic status in murine C2C12 myoblasts. This method is superior over the direct addition of recombinant bFGF into culture media because commercial bFGF is usually produced by E. coli and its bioactivity is subject to fluctuation. Mouse C2C12 myoblast is a well characterized myogenic cell line to recapitulate myogenesis in vitro. When cultured in a medium containing low concentrations of mitogens proliferating C2C12 myoblasts would withdraw irreversibly from the cell cycle, express muscle-specific genes and fuse into mature myotubes. Hence, by producing exogenous bFGF in myoblasts and looking at the expression of endogenous myostatin gene could simplify experimental design and prove unambiguously the effects of bFGF on the expression of the myostatin gene, as well as its working mode. The results in our experiment were clear-cut in that bFGF suppressed myostatin gene expression.
In our experiment, cells expressing bFGF gene transiently produced much more mRNA and protein than cells carrying integrated bFGF gene cassette. This has many reasons: first, many cells in a culture dish could uptake vector DNA and the strong CMV promoter could drive bFGF gene to produce lots of protein in a short time; second, only a small part of vector DNA entering the cell had the chance to integrate into cell genomes and the rest would be lost following the division of cells; and third, even for those sequences integrated onto chromosome loci, its expression would subject the regulation of the gene environments (position effect). Therefore, unless through strict selection to enrich higher expression cells, transient expression tended to produce more protein than integrated expression.
The mechanism of myostatin gene suppression by bFGF is not clear. According to previous reports [30] , the pleiotropic effects of bFGF are transduced by its interaction with any one of four members of a high-affinity cell surface FGF receptor family. These receptors are single pass transmembrane proteins with kinase activities that induce phosphorylation of tyrosine residues in the receptor itself. bFGF triggers a series of signaling transduction cascades including mitogen-activated protein (MAP)-kinase. MAPkinase family members comprise extracellular signalregulated kinase (ERK)1/2, c-Jun N-terminal kinase (JNK), p38 MAP kinase and so on. Background researches have proven that bFGF activates different members of the MAPkinase family to exert its biological roles on different cells [30, 33] . Therefore, following activation of MAP-kinase, the expression of myostatin gene will be inhibited. Further investigation is needed to determine what contributes to the signaling cascades of suppression of bFGF on expression of myostatin in skeletal muscle.
As a negative regulator of skeletal muscle, myostatin interacts with several growth factors including insulin-like growth and bFGF in stimulation of skeletal muscle growth. However, further investigation is needed to elucidate the exact nature of bFGF action in regulating biological roles of myostatin.
